Your Podsite trial is ending soon. Put the final touches on it with our tips on how to make a great podcast website.

Claim your custom domain name todayClaim your domain

Coffee Talk: Why is Digital Health Important to Biopharmaceutical Companies?

13 minutes

The pandemic has illustrated how Social Determinants of Health (SDOH) can impact the spread of disease, access to vaccines and the levels of trust in and utilization of basic health services.

Beyond the focus on SDOH by politicians, advocacy, groups, and charitable organizations, there are private and public commercial organizations that make it a priority to find and fund solutions that address the social and cultural barriers that reduce or limit access to care.

One of those organizations is Bayer.

In this conversation with Dominick Kennerson, Global Head of Bayer G4A, we discuss how equity, access and sustainability help set the course for their investment strategy.


This Coffee Talk is created in partnership with our Sponsor, Bayer G4A. This year Bayer G4A is looking for companies creating solutions to 5 key challenges including oncology, radiology, mental health, women's health and cardio metabolic and renal diseases.  

The Bayer G4A program is open to companies from pre-seed stage to Series A, and even more advanced companies with traction in the market. Apply to be a part of Bayer G4A here, and tell them you heard about it on Digital Health Today.

The deadline to apply is June 20, 2021.


Guest Links and Resources:


Host Links


Connect on Digital Health Today:

Browse Episodes | Twitter | Linkedin | Facebook | Instagram


Connect on Health Podcast Network:

Browse Shows | Linkedin | Twitter | Facebook | Instagram

More episodes from Digital Health Today 360 with Dan Kendall

S12: #113: Jane Sarasohn-Kahn on Women's Health, Social Determinants of Health, and the 'She-cession'

Guest host Sophie Park interviews health economist Jane Sarasohn-Kahn for this fast-paced discussion about women's health, social determinants of health and the 'she-cession' in the wake of …

Coffee Talk: H2O - How the Health Outcomes Observatory Gives Patients Better Tools and Bigger Voices

Every day, tech companies and governments frame the conversation around the use of data. With the proliferation of smartphones and wearable devices, …

S12: #112 "The dumbest thing I'd ever done...that began the career path that I still am on today" with Dr. David E. Albert, Founder of AliveCor

Dr. David E Albert is a physician, engineer, inventor and serial entrepreneur, and he's the founder and Chief Medical Officer of Alivecor. Dr. Albert …

S12: #111: How to Uber a Diabetes Business Before It Gets Kodak-ed

In this episode, we dive into a topic that is very close to my heart: improving the lives of people with diabetes.


You've certainly heard Kodak mentioned as a good example of how companies …

S11: #110 Introducing the Host of the New Asia Pacific Edition: Tony Estrella

"In this episode, I'm excited to introduce you to yet another outstanding health innovation leader who is hosting another new show on Digital Health Today. His degrees are in engineering …

S11: #109 Introducing the Host of the new Digital Therapeutics Podcast: Eugene Borukhovich

In this episode, I have the pleasure of introducing you to one of the health sectors leading innovators, and probably one of the best known and, dare I say it, most loved, leaders I’ve had …

How you can listen to this podcast

You can listen to episodes right here on the website, or if you prefer, in a podcast app. Listening in an app makes it easier to keep track of what you’ve already heard, listen without using your data plan and many other conveniences.

Recommended apps
Start listening to S12: #113: Jane Sarasohn-Kahn on Women's Health, Social Determinants of Health, and the 'She-cession'
27:23
Start listening to S12: #113: Jane Sarasohn-Kahn on Women's Health, Social Determinants of Health, and the 'She-cession'
27:23